SYMBIOTEC PHARMALAB LTD
Latest filings
- Revised pledge disclosure by Symbiotec Pharmalab promoters · Ownership Changes
- Routine filing: Registrar confirms Q2 demat activity processed · Compliance
- Knovea signs exclusive US commercialization deal for two DCV injectables with global pharma major · Strategic Transactions
Snapshot
What the business is, and whether it's a good one at a fair price.
A listed company listed on NSE and BSE.
Charts
How has the market priced it — with filings on the timeline?
SYMBIOTEC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from SYMBIOTEC PHARMALAB LTD's filed financials and exchange disclosures
What does SYMBIOTEC PHARMALAB LTD do?
SYMBIOTEC PHARMALAB LTD is listed on NSE and BSE, trading under the symbol SYMBIOTEC.
Where can I track SYMBIOTEC PHARMALAB LTD's announcements?
Every NSE and BSE filing by SYMBIOTEC PHARMALAB LTD appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.